M. Lacombe

5.3k total citations · 1 hit paper
99 papers, 4.1k citations indexed

About

M. Lacombe is a scholar working on Nuclear and High Energy Physics, Molecular Biology and Epidemiology. According to data from OpenAlex, M. Lacombe has authored 99 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Nuclear and High Energy Physics, 21 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in M. Lacombe's work include Quantum Chromodynamics and Particle Interactions (18 papers), Nuclear physics research studies (17 papers) and Particle physics theoretical and experimental studies (16 papers). M. Lacombe is often cited by papers focused on Quantum Chromodynamics and Particle Interactions (18 papers), Nuclear physics research studies (17 papers) and Particle physics theoretical and experimental studies (16 papers). M. Lacombe collaborates with scholars based in France, Netherlands and Canada. M. Lacombe's co-authors include B. Loiseau, R. Vinh Mau, R. de Tourreil, Pedro Pires, J. M. Richard, Jean‐François Côté, W. N. Cottingham, Joost Coté, Rupert Mutzel and Robbert J. Kok and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Biological Chemistry.

In The Last Decade

M. Lacombe

96 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parametrization of the ParisN−Npotential

1980 1.1k citations M. Lacombe, B. Loiseau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Lacombe France	30	2.2k	1.0k	704	335	222	99	4.1k
Alberto Gobbi Italy	42	2.1k 1.0×	2.2k 2.2×	1.3k 1.8×	153 0.5×	127 0.6×	128	8.9k
Hiroshi Amemiya Japan	33	342 0.2×	988 1.0×	641 0.9×	176 0.5×	273 1.2×	294	4.4k
Yasuhiro Kuramitsu Japan	33	605 0.3×	1.8k 1.8×	214 0.3×	100 0.3×	242 1.1×	217	4.0k
F. E. Bertrand United States	27	1.1k 0.5×	1.1k 1.1×	571 0.8×	140 0.4×	93 0.4×	81	3.3k
Naoki Iwamoto Japan	34	522 0.2×	1.2k 1.2×	732 1.0×	230 0.7×	135 0.6×	233	4.9k
Иван Тодоров United States	49	1.0k 0.5×	2.9k 2.9×	658 0.9×	165 0.5×	128 0.6×	228	7.8k
J. Delaunay France	44	550 0.2×	2.1k 2.1×	292 0.4×	166 0.5×	61 0.3×	341	7.6k
Richard A. Ward United States	41	521 0.2×	1.9k 1.8×	304 0.4×	133 0.4×	129 0.6×	150	5.5k
Takashi Ishikawa Japan	44	649 0.3×	1.8k 1.8×	955 1.4×	483 1.4×	331 1.5×	440	8.3k
Takashi Okamura Japan	37	944 0.4×	1.4k 1.4×	206 0.3×	770 2.3×	70 0.3×	294	6.1k

Countries citing papers authored by M. Lacombe

Since Specialization

Citations

This map shows the geographic impact of M. Lacombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lacombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lacombe more than expected).

Fields of papers citing papers by M. Lacombe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lacombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lacombe. The network helps show where M. Lacombe may publish in the future.

Co-authorship network of co-authors of M. Lacombe

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lacombe. A scholar is included among the top collaborators of M. Lacombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lacombe. M. Lacombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rousseau, Caroline, Ludovic Ferrer, M. Lacombe, et al.. (2021). Automatic Segmentation of Metastatic Breast Cancer Lesions on 18F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment. Cancers. 14(1). 101–101. 18 indexed citations

Paumier, A., P. Trémolières, M. Lacombe, et al.. (2016). Valeur pronostique du volume tumoral métabolique sur la TEP au (18F)-fluorodésoxyglucose préthérapeutique pour le cancer de l’œsophage localisé. Cancer/Radiothérapie. 20(1). 24–29. 2 indexed citations

Chabot, Guylaine & M. Lacombe. (2014). Factors Influencing the Intention of Perinatal Nurses to Adopt the Baby-Friendly Hospital Initiative in Southeastern Quebec, Canada: Implications for Practice. Nursing Research and Practice. 2014. 1–8. 4 indexed citations

Stokman, Geurt, Yu Qin, Tijmen H. Booij, et al.. (2014). Epac-Rap Signaling Reduces Oxidative Stress in the Tubular Epithelium. Journal of the American Society of Nephrology. 25(7). 1474–1485. 32 indexed citations

Altıntaş, Işıl, Raimond Heukers, Roy van der Meel, et al.. (2012). Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. Journal of Controlled Release. 165(2). 110–118. 97 indexed citations

Beuge, Marike Marjolijn van, Jai Prakash, M. Lacombe, et al.. (2011). Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice. Journal of Pharmacology and Experimental Therapeutics. 337(3). 628–635. 51 indexed citations

Beuge, Marike Marjolijn van, Jai Prakash, M. Lacombe, et al.. (2011). Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632. Pharmaceutical Research. 28(8). 2045–2054. 33 indexed citations

Dolman, M. Emmy M., Ebel H. E. Pieters, Rolf W. Sparidans, et al.. (2011). Dendrimer‐Based Macromolecular Conjugate for the Kidney‐Directed Delivery of a Multitargeted Sunitinib Analogue. Macromolecular Bioscience. 12(1). 93–103. 18 indexed citations

Dolman, M. Emmy M., M. Lacombe, János Pató, et al.. (2011). Imatinib-ULS-lysozyme: A proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases. Journal of Controlled Release. 157(3). 461–468. 26 indexed citations

10.

Dolman, M. Emmy M., Marjan M. Fretz, M. Lacombe, et al.. (2008). Renal targeting of kinase inhibitors. International Journal of Pharmaceutics. 364(2). 249–257. 19 indexed citations

11.

Prakash, Jai, Martin H. de Borst, M. Lacombe, et al.. (2008). Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis. Pharmaceutical Research. 25(10). 2427–2439. 38 indexed citations

12.

Gonzalo, Teresa, Leonie Beljaars, M. van de Bovenkamp, et al.. (2007). Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells. Journal of Pharmacology and Experimental Therapeutics. 321(3). 856–865. 61 indexed citations

13.

Sloot, Almer M. van der, Kai Temming, M. Lacombe, et al.. (2007). RGD-avidin–biotin pretargeting to αvβ3 integrin enhances the proapoptotic activity of TNFα related apoptosis inducing ligand (TRAIL). APOPTOSIS. 13(2). 225–235. 9 indexed citations

14.

Prakash, Jai, Maria Sandovici, Vinay Saluja, et al.. (2006). Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1 H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 319(1). 8–19. 53 indexed citations

15.

Temming, Kai, M. Lacombe, Roel Q.J. Schaapveld, et al.. (2006). Rational Design of RGD–Albumin Conjugates for Targeted Delivery of the VEGF‐R Kinase Inhibitor PTK787 to Angiogenic Endothelium. ChemMedChem. 1(11). 1200–1203. 29 indexed citations

16.

Temming, Kai, M. Lacombe, Sigrídur A. Ásgeirsdóttir, et al.. (2006). Targeting of the VEGF-kinase inhibitor PTK787 to angiogenic vasculature using RGD-equipped albumin carrier molecules. Journal of Controlled Release. 116(2). e57–e57. 2 indexed citations

17.

Fournier, A., J Vaysse, & M. Lacombe. (1978). Rein et hypertension artérielle : possibilités thérapeutiques. 1 indexed citations

18.

Richard, J. M., M. Lacombe, & R. Vinh Mau. (1976). NN bound states and resonances near threshold from ππ, πN, NN interactions. Physics Letters B. 64(2). 121–124. 23 indexed citations

19.

Mau, R. Vinh, J. M. Richard, B. Loiseau, M. Lacombe, & W. N. Cottingham. (1973). Nucleon-nucleon interaction from pion-nucleon phase shift analysis. Physics Letters B. 44(1). 1–4. 40 indexed citations

20.

Cachera, J P, et al.. (1969). Allogenic Grafts of the Heart in Dogs Treated with an Anti-Dog Lymphocyte Serum or Globulin. European Surgical Research. 1(1). 26–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact